Stocks Overview

LAST PRICE
39.8000
TODAY'S CHANGE (%)
Trending Up0.7500 (1.9206%)

Bid / Lots
38.5200/ 10
Ask / Lots
41.2300/ 1
Open / Previous Close
39.2900 / 39.0500
Day Range
Low 38.5100
High 40.0000
52 Week Range
Low 31.5200
High 54.5600
Volume
1,225,714
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 39.05
Time	Volume	RARE
09:32 ET	17798	39.135
09:34 ET	1234	39
09:36 ET	854	39.015
09:38 ET	2208	38.765
09:39 ET	4826	38.685
09:41 ET	6082	38.65
09:43 ET	8372	38.61
09:45 ET	900	38.9
09:48 ET	775	38.94
09:50 ET	3904	39.12
09:52 ET	509	39.19
09:54 ET	7597	38.98
09:56 ET	1675	39.02
09:57 ET	400	39
09:59 ET	2544	38.99
10:01 ET	900	38.99
10:03 ET	3882	38.87
10:06 ET	3474	38.63
10:08 ET	5587	38.595
10:10 ET	3557	38.63
10:12 ET	3434	38.7
10:14 ET	990	38.61
10:15 ET	2880	38.75
10:17 ET	2823	38.93
10:19 ET	1144	38.98
10:21 ET	831	38.84
10:24 ET	1659	38.75
10:26 ET	919	38.8018
10:28 ET	800	38.86
10:30 ET	900	38.81
10:32 ET	606	38.765
10:33 ET	3353	38.87
10:35 ET	3496	39.07
10:37 ET	1000	39
10:39 ET	876	38.97
10:42 ET	600	38.945
10:44 ET	601	38.935
10:46 ET	392	38.9185
10:48 ET	400	38.935
10:50 ET	2185	38.96
10:51 ET	10965	39.06
10:53 ET	900	39.08
10:55 ET	1394	39.11
10:57 ET	1150	39.35
11:00 ET	1300	39.55
11:02 ET	4721	39.435
11:04 ET	1220	39.4001
11:06 ET	2788	39.45
11:08 ET	3847	39.41
11:09 ET	2027	39.51
11:11 ET	1977	39.4
11:13 ET	600	39.33
11:15 ET	2876	39.2
11:18 ET	102	39.2
11:20 ET	1159	39.09
11:22 ET	704	39.065
11:24 ET	4151	39.095
11:26 ET	400	39.03
11:27 ET	4189	39.2
11:29 ET	677	39.12
11:31 ET	1192	39.08
11:33 ET	100	39.07
11:36 ET	4113	39.03
11:38 ET	931	39.04
11:40 ET	2447	39.19
11:42 ET	2267	39.28
11:44 ET	200	39.25
11:45 ET	1469	39.34
11:47 ET	3409	39.55
11:49 ET	6330	39.33
11:51 ET	302	39.3
11:54 ET	5451	39.325
11:56 ET	561	39.335
11:58 ET	200	39.36
12:00 ET	200	39.36
12:02 ET	2306	39.46
12:03 ET	3329	39.49
12:05 ET	200	39.485
12:07 ET	554	39.45
12:09 ET	295	39.46
12:12 ET	4626	39.56
12:14 ET	2211	39.53
12:16 ET	4662	39.37
12:18 ET	1332	39.32
12:20 ET	1271	39.27
12:21 ET	1565	39.25
12:23 ET	300	39.245
12:25 ET	100	39.245
12:27 ET	2389	39.245
12:30 ET	2653	39.21
12:32 ET	3347	39.26
12:34 ET	605	39.245
12:36 ET	1147	39.14
12:38 ET	5117	39.06
12:39 ET	100	39.075
12:41 ET	170	39.11
12:43 ET	712	39.1
12:45 ET	4136	39.13
12:48 ET	1592	39.18
12:50 ET	349	39.18
12:52 ET	1503	39.19
12:54 ET	760	39.21
12:56 ET	900	39.205
12:57 ET	2350	39.32
12:59 ET	4942	39.31
01:01 ET	300	39.315
01:06 ET	3763	39.435
01:08 ET	1400	39.465
01:10 ET	308	39.5
01:12 ET	5023	39.42
01:14 ET	200	39.42
01:15 ET	441	39.42
01:17 ET	6730	39.55
01:19 ET	3431	39.62
01:21 ET	2635	39.68
01:24 ET	1757	39.6695
01:26 ET	500	39.61
01:28 ET	707	39.655
01:30 ET	200	39.68
01:32 ET	3226	39.63
01:33 ET	3179	39.535
01:35 ET	3057	39.64
01:39 ET	200	39.65
01:42 ET	1000	39.69
01:44 ET	4620	39.8
01:46 ET	2638	39.86
01:48 ET	2915	39.82
01:50 ET	256	39.83
01:51 ET	3780	39.92
01:53 ET	600	39.98
01:55 ET	1902	39.97
01:57 ET	10612	39.86
02:00 ET	2700	39.86
02:02 ET	6703	39.845
02:04 ET	7353	39.86
02:06 ET	1136	39.865
02:08 ET	13208	39.8975
02:09 ET	902	39.98
02:11 ET	3972	39.905
02:13 ET	712	39.9
02:15 ET	2650	39.785
02:18 ET	403	39.82
02:20 ET	1100	39.77
02:22 ET	3510	39.7013
02:24 ET	667	39.69
02:26 ET	633	39.65
02:27 ET	1600	39.715
02:29 ET	498	39.75
02:31 ET	2400	39.8
02:33 ET	1857	39.755
02:36 ET	1495	39.66
02:38 ET	6280	39.61
02:40 ET	12548	39.7
02:42 ET	200	39.72
02:44 ET	1047	39.76
02:45 ET	400	39.755
02:47 ET	4280	39.765
02:49 ET	100	39.765
02:51 ET	2997	39.77
02:54 ET	100	39.76
02:56 ET	6563	39.66
02:58 ET	2293	39.655
03:00 ET	1440	39.665
03:02 ET	358	39.685
03:03 ET	900	39.715
03:05 ET	6772	39.76
03:07 ET	6660	39.72
03:09 ET	100	39.76
03:12 ET	418	39.76
03:14 ET	2310	39.73
03:16 ET	3528	39.76
03:18 ET	26705	39.77
03:20 ET	2698	39.71
03:21 ET	9255	39.815
03:23 ET	1409	39.815
03:25 ET	4956	39.825
03:27 ET	10268	39.86
03:30 ET	2901	39.87
03:32 ET	6959	39.79
03:34 ET	783	39.78
03:36 ET	7983	39.765
03:38 ET	6553	39.805
03:39 ET	782	39.805
03:41 ET	2726	39.76
03:43 ET	3569	39.66
03:45 ET	7102	39.7
03:48 ET	10323	39.7
03:50 ET	15244	39.795
03:52 ET	13566	39.8
03:54 ET	12200	39.81
03:56 ET	33051	39.91
03:57 ET	22681	39.84
03:59 ET	185862	39.8

Data delayed at least 15 minutes.

Jun 13, 2024
- *DJ Ultragenyx Prices Public Offering of Stock, Prefunded Warrants >RARE, from 8:50PM ET on Thursday Jun 13, 2024 by Dow Jones
  8:50PM ET on Thursday Jun 13, 2024 by Dow Jones
- Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants, from 8:49PM ET on Thursday Jun 13, 2024 by Dow Jones
  8:49PM ET on Thursday Jun 13, 2024 by Dow Jones
- DJ Ultragenyx Shares Slip Premarket on Planned Stock Offering, from 6:04AM ET on Thursday Jun 13, 2024 by Dow Jones
  6:04AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
- DJ Ultragenyx Pharmaceuticals to Seek Accelerated Approval of Genetic Disease Treatment, from 4:11PM ET on Wednesday Jun 12, 2024 by Dow Jones
  4:11PM ET on Wednesday Jun 12, 2024 by Dow Jones
- Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, from 4:05PM ET on Wednesday Jun 12, 2024 by Dow Jones
  4:05PM ET on Wednesday Jun 12, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRARE Ultragenyx Pharmaceutical Inc	3.2B	-5.0x	---
United StatesFOLD Amicus Therapeutics Inc	3.0B	-20.4x	---
United StatesDNLI Denali Therapeutics Inc	3.0B	-21.2x	---
United StatesGH Guardant Health Inc	3.7B	-7.8x	---
United StatesARWR Arrowhead Pharmaceuticals Inc	3.2B	-5.9x	---
United StatesGMAB Genmab A/S	17.4B	21.7x	+22.71%
As of 2024-06-17

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultrarare genetic diseases. Its therapies and clinical-stage pipeline consist of four product categories: biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO), Mepsevii (vestronidase alfa) for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome, Dojolvi (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD), and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia (HoFH). Its clinical product candidates include DTX401, DTX301, and UX701. DTX401 for the treatment of glycogen storage disease type la.

Contact Information

Headquarters: 60 Leveroni CtNOVATO, CA, United States 94949-5746
Phone: 415-483-8800
Fax: 415-483-8810

Executives

Independent Chairman of the Board: Daniel Welch
President, Chief Executive Officer, Director: Emil Kakkis
Chief Financial Officer, Executive Vice President, Corporate Strategy: Howard Horn
Executive Vice President, Chief Technical Operations Officer and Gene Therapy Operations: Dennis Huang
Executive Vice President, Chief Legal Officer, General Counsel: Karah Parschauer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.2B
Revenue (TTM)	$442.6M
Shares Outstanding	83.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.55
EPS	$-8.02
Book Value	$3.35
P/E Ratio	-5.0x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	---
Operating Margin	-131.15%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Ultragenyx Pharmaceutical Inc
NASDAQ:RAREUnited States

Search Criteria

Charts

Recent News

Jun 13, 2024

*DJ Ultragenyx Prices Public Offering of Stock, Prefunded Warrants >RARE, from 8:50PM ET on Thursday Jun 13, 2024 by Dow Jones

Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants, from 8:49PM ET on Thursday Jun 13, 2024 by Dow Jones

DJ Ultragenyx Shares Slip Premarket on Planned Stock Offering, from 6:04AM ET on Thursday Jun 13, 2024 by Dow Jones

Jun 12, 2024

DJ Ultragenyx Pharmaceuticals to Seek Accelerated Approval of Genetic Disease Treatment, from 4:11PM ET on Wednesday Jun 12, 2024 by Dow Jones

Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, from 4:05PM ET on Wednesday Jun 12, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar